Edwards Lifesciences · Operating Cash Flow (Statement)

EW Operating Cash Flow (Statement)

Latest reported$651.90Mperiod endingJun 30, 2026

EW Quarterly Cash from Operations ($69.00M → $651.90M)

Quarterly operating cash flow (statement)

High-resolution chart · PNG

EW operating cash flow (statement) history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Edwards Lifesciences Operating Cash Flow (Statement) — Quarterly (USD)
Period ending	Operating Cash Flow (Statement) (USD)
Jun 30, 2026	651,900,000
Mar 31, 2026	43,800,000
Dec 31, 2025	450,900,000
Sep 30, 2025	573,700,000
Jun 30, 2025	290,200,000
Mar 31, 2025	280,400,000
Dec 31, 2024	-127,500,000
Sep 30, 2024	351,800,000
Jun 30, 2024	371,500,000
Mar 31, 2024	-53,500,000
Dec 31, 2023	136,600,000
Sep 30, 2023	411,500,000
Jun 30, 2023	33,600,000
Mar 31, 2023	314,100,000
Dec 31, 2022	282,800,000
Sep 30, 2022	309,900,000
Jun 30, 2022	332,200,000
Mar 31, 2022	293,300,000
Dec 31, 2021	373,600,000
Sep 30, 2021	531,900,000
Jun 30, 2021	526,100,000
Mar 31, 2021	300,500,000
Dec 31, 2020	400,000,000
Sep 30, 2020	216,100,000
Jun 30, 2020	231,200,000
Mar 31, 2020	207,000,000
Dec 31, 2019	399,400,000
Sep 30, 2019	437,300,000
Jun 30, 2019	341,200,000
Mar 31, 2019	1,500,000
Dec 31, 2018	293,000,000
Sep 30, 2018	342,300,000
Jun 30, 2018	140,200,000
Mar 31, 2018	151,300,000
Dec 31, 2017	363,900,000
Sep 30, 2017	310,800,000
Jun 30, 2017	197,700,000
Mar 31, 2017	128,300,000
Dec 31, 2016	201,100,000
Sep 30, 2016	205,900,000
Jun 30, 2016	190,300,000
Mar 31, 2016	107,100,000
Dec 31, 2015	103,800,000
Sep 30, 2015	202,500,000
Jun 30, 2015	170,100,000
Mar 31, 2015	73,300,000
Dec 31, 2014	93,200,000
Sep 30, 2014	12,200,000
Jun 30, 2014	778,000,000
Mar 31, 2014	138,900,000
Dec 31, 2013	111,300,000
Sep 30, 2013	147,100,000
Jun 30, 2013	127,000,000
Mar 31, 2013	87,300,000
Dec 31, 2012	126,400,000
Sep 30, 2012	131,300,000
Jun 30, 2012	146,800,000
Mar 31, 2012	-30,700,000
Dec 31, 2011	143,100,000
Sep 30, 2011	97,200,000
Jun 30, 2011	59,300,000
Mar 31, 2011	14,900,000
Dec 31, 2010	94,000,000
Sep 30, 2010	96,400,000
Jun 30, 2010	48,000,000
Mar 31, 2010	13,000,000
Dec 31, 2009	65,900,000
Sep 30, 2009	71,500,000
Jun 30, 2009	63,900,000
Mar 31, 2009	-36,000,000
Dec 31, 2008	80,500,000
Sep 30, 2008	13,800,000
Jun 30, 2008	29,000,000
Mar 31, 2008	29,900,000
Dec 31, 2007	76,900,000
Sep 30, 2007	59,400,000
Jun 30, 2007	37,800,000
Mar 31, 2007	36,100,000
Dec 31, 2006	70,000,000
Sep 30, 2006	60,200,000
Jun 30, 2006	39,600,000
Mar 31, 2006	61,000,000
Dec 31, 2005	44,300,000
Sep 30, 2005	39,000,000
Jun 30, 2005	32,600,000
Mar 31, 2005	20,900,000
Dec 31, 2004	50,900,000
Sep 30, 2004	64,900,000
Jun 30, 2004	28,700,000
Mar 31, 2004	36,100,000
Dec 31, 2003	68,400,000
Sep 30, 2003	26,400,000
Jun 30, 2003	36,100,000
Mar 31, 2003	-8,600,000
Dec 31, 2002	47,200,000
Sep 30, 2002	30,700,000
Jun 30, 2002	43,600,000
Mar 31, 2002	-900,000
Dec 31, 2001	46,500,000
Sep 30, 2001	28,500,000